跳至主要内容
临床试验/NCT00969969
NCT00969969已完成3 期

A Study to Evaluate the Effectiveness and Safety of an Implant in the Treatment of Osteoarthritis of the Great Toe

Cartiva, Inc.23 个研究点 分布在 2 个国家目标入组 236 人开始时间: 2009年8月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
Cartiva, Inc.
入组人数
236
试验地点
23
主要终点
VAS, FAAM, Safety

研究概览

简要总结

This study will evaluate whether Cartiva is an effective treatment for individuals with osteoarthritis of the great toe.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥ 18 years of age
  • Osteoarthritis of the first metatarsophalangeal joint and is a candidate for arthrodesis
  • Presence of good bone stock
  • Capable of completing self-administered questionnaires

排除标准

  • < 18 years of age
  • Osteoarthritis of the first metatarsophalangeal joint, though is not a candidate for arthrodesis
  • Active bacterial infection of the foot
  • Additional ipsilateral limb (hip, knee, ankle, or foot) pathology that requires active treatment (surgery or brace)

结局指标

主要结局

VAS, FAAM, Safety

时间窗: up to 2 years

The individual components of the primary outcome measures will be Visual Analog Scale (VAS) Pain, Foot and Ankle Ability Measure (FAAM) Sports sub-scale score and absence of key safety issues.

次要结局

未报告次要终点

研究者

发起方
Cartiva, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (23)

Loading locations...

相似试验